Silo Pharma Ownership 2024 | Who Owns Silo Pharma Now?
Insider Ownership
4.13%
Silo Pharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FIDELITY CONCORD STREET TRUST | 0.00% | 16,106 | -73 | -0.45% | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 16,334 | -16,334 | -50.00% | Mar 31, 2024 |
Silo Pharma's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 16.11K shares, compromising 0.00% of its total assets.
Silo Pharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
The last insider buy of SILO was made by Weisblum Eric on Jun 13 2024, buying 4,438 shares at $1.11 per share (worth $4.93K).
Silo Pharma Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 5 | - | - |
| Q1 2024 | 1 | - | - |
| Q4 2023 | 15 | - | - |
| Q2 2023 | 3 | - | - |
| Q4 2022 | 4 | - | - |
| Q3 2022 | - | 1 | - |
| Q2 2022 | 1 | - | - |
| Q4 2021 | 6 | - | - |
| Q4 2020 | - | - | - |
| Q2 2020 | 2 | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | 3 | - | - |
| Q2 2019 | 1 | - | - |
| Q1 2016 | - | 1 | - |
| Q3 2015 | - | - | - |
| Q1 2015 | 3 | - | - |
| Q3 2014 | 1 | 5 | 20.00% |
| Q1 2014 | - | - | - |
| Q2 2013 | 2 | - | - |
| Q1 2013 | - | - | - |
5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Silo Pharma's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 5 | - | - |
| Q1 2024 | 1 | - | - |
| Q4 2023 | 15 | - | - |
| Q2 2023 | 3 | - | - |
| Q4 2022 | 4 | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 1 | - | - |
| Q4 2021 | 2 | - | - |
| Q4 2020 | - | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | 2 | - | - |
| Q2 2019 | 1 | - | - |
| Q1 2016 | - | - | - |
| Q3 2015 | - | - | - |
| Q1 2015 | - | - | - |
| Q3 2014 | - | - | - |
| Q1 2014 | - | - | - |
| Q2 2013 | - | - | - |
| Q1 2013 | - | - | - |
As of Q2 2024, Insider owners conducted 5 open market buy trades and 0 open market sell trades of Silo Pharma's stocks.
Silo Pharma Peer Ownership
| Ticker | Company |
|---|---|
| IVA | Inventiva S.A. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| HOOK | HOOKIPA Pharma Inc. |
| IPSC | Century Therapeutics, Inc. |
| CSBR | Champions Oncology, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| RZLT | Rezolute, Inc. |
| INDP | Indaptus Therapeutics, Inc. |
| TPST | Tempest Therapeutics, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| URGN | UroGen Pharma Ltd. |
| BCDA | BioCardia, Inc. |
| PRDS | Pardes Biosciences, Inc. |
| FBRX | Forte Biosciences, Inc. |
| STTK | Shattuck Labs, Inc. |
| LUMO | Lumos Pharma, Inc. |
| ELYM | Eliem Therapeutics, Inc. |